Dhansa Labs Limited (NSE:DHANSA)

Market Cap	515.15M -55.0%
Revenue (ttm)	1.43B +7.5%
Net Income	55.23M +15.5%
EPS	2.21 +7.4%
Shares Out	24.95M
PE Ratio	9.34
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,000
Open	20.50
Previous Close	21.50
Day's Range	20.50 - 20.70
52-Week Range	16.20 - 48.30
Beta	1.07
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Dhansa Labs

Dhansa Labs Limited manufactures and distributes agro chemicals and home hygiene products in India. The company offers 2,4-D acid tech, sodium salt, amine salt, ethyl hexyl ester tech, and ethyl ester tech; and chlorpyriphos, thiamethoxam, pretilachlor, metribuzin, hexaconazole, clodinofob tech, and lambda cyhalothrine tech. It also exports its products. The company was formerly known as Ambey Laboratories Limited and changed its name to Dhansa Labs Limited in March 2026. Dhansa Labs Limited was incorporated in 1985 and is based in Gurugram, In...

• Industry: Agricultural Chemicals
• Founded: 1985
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: DHANSA

Financial Performance

In fiscal year 2026, Dhansa Labs's revenue was 1.43 billion, an increase of 7.48% compared to the previous year's 1.33 billion. Earnings were 55.23 million, an increase of 15.47%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 26, 2026

Data Sources Report a data error